v3.22.2.2
INVESTMENTS IN ASSOCIATES - Hyasynth Biologicals Inc. (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 22, 2021
CAD ($)
Sep. 12, 2018
CAD ($)
tranches
$ / shares
shares
Aug. 31, 2022
CAD ($)
Aug. 31, 2021
CAD ($)
Oct. 23, 2020
CAD ($)
Disclosure of associates [line items]          
Number of tranches | tranches   3      
Purchase of interests in associates     $ 2,624 $ 2,539  
CBD supply agreement (in years)     10 years    
Hyasynth Biologicals Inc          
Disclosure of associates [line items]          
Purchase of interests in associates $ 10,000 $ 10,000      
Participating share 49.90% 49.90% 49.90%    
Ability to purchase up to annual cannabinoid or cannabinoid related production     100.00%    
Percentage of discount agreed upon wholesale market price for period of ten years     10.00%    
Convertible debentures receivable, face value     $ 5,000    
Convertible debentures, conversion price | $ / shares   $ 40      
Convertible debentures, total number of shares available upon conversion | shares   125,000      
Hyasynth Biologicals Inc | Achievement Of Contractual Production Related Milestone          
Disclosure of associates [line items]          
Potential proportion of ownership interest in associate     8.00%    
Advance given as convertible debentures $ 2,500       $ 2,500